Biotech news

[magolibero]

Nel documento da te citato a pag 15 parla del 2° trimestre del 2011, non so dirti se in anticipo. qui si dice del 3° trimestre.

ho aperto un 3ad BNVI dedicato

http://www.investireoggi.it/forum/b...na-cinese-al-biotech-vt64695.html#post2319028

..sia mai che la cosa diventi "interessante" ..e ci possano essere più notizie e/o occasioni di confrontarsi

 

[Sheppy]

x info.... CHTP

CHARLOTTE, N.C., July 26, 2011 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. announced positive top-line results of an investigator-led Phase II clinical study of droxidopa in combination with carbidopa in adults with attention deficit hyperactivity disorder (ADHD).

Preliminary Data From Exploratory Phase II Study Demonstrates Significant Activity of Droxidopa in Adult Attention Deficit Hyperactivity Disorder (ADHD) - Yahoo! Finance

 

[Zohar]

Aastrom Announces Agreement From FDA on Special Protocol Assessment for Phase 3 Clinical Trial in No-Option Critical Limb Ischemia Patients - MarketWatch

 

[Zohar]

PR-USA.net - Promising Products From AEterna Zentaris and Celsion Eager to Defy Odds

 

[Zohar]

PR-USA.net - Keryx Biopharmaceuticals Announces Completion of Patient Enrollment in KRX-0401 (Perifosine) Phase 3

 

[Zohar]

ADVENTRX Receives Complete Response Letter for Exelbine NDA -- SAN DIEGO, Aug. 9, 2011 /PRNewswire/ --

 

[Zohar]

Weekly Update: CEL-SCI Receives FDA Warning Letter in relation to Web Site Declarations on Multikine | Galaxy Stocks

 

[Zohar]

Aeterna Zentaris to Present Poster on Novel Oral Anticancer Erk Inhibitors at Upcoming American Chemical Society's National Meeting - MarketWatch

 

[DickSIM]

ciao Maghetto! chissà se in Canada....

QLT Shows Positive 4 Week Efficacy in Phase II Study for Glaucoma Using Latanoprost Punctal Plug Delivery System - MarketWatch

ci danno tot QLT per la cioffeca massima!

 

[DickSIM]

2 Healthcare Companies Expecting September Catalysts - Seeking Alpha